Bunge Global’s (NYSE:BG) Q3 2026 sales top estimates

Bunge Global (NYSE: BG) reported Q3 2026 revenue of $23.8B, up 7.4% YoY, beating estimates. Non-GAAP EPS was $2.56, 5.6% above consensus. Analysts expect 1.8% revenue decline next 12 months. Free cash flow margin was negative 6.6% in Q3.

Original reporting
Published Oct 29, 2026, 10:21 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 11:18 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Bunge Global’s (NYSE:BG) Q3 2026 sales top estimates — source image
Decision brief

The 30-second read

$BGNeutralMed
01

Why it matters

Traders may reprice near-term quality of earnings because the report combines an earnings beat with a gross margin miss and a large cash outflow, plus an expectation of revenue decline over the next 12 months.

02

Market read

A company-specific earnings print with mixed signals: revenue and EPS beat, but gross margin and free cash flow deterioration raise caution.

03

What to watch

The article does not quantify segment drivers or guidance details beyond a broad next-12-month revenue decline expectation, which may be the key swing factor for traders.

Relevance 7/10Novelty 6/10Timing: after-hours or same-day post-earnings read-through, shares noted flat immediately after the report

Background

The piece is a Q3 2026 results write-up for Bunge Global, comparing reported revenue and non-GAAP EPS to Wall Street consensus and discussing cash flow and margins.

Company-level read

Ticker impact

$BGNeutralMedium confidence
Context

Bunge Global reported Q3 2026 revenue of $23.8B, up 7.4% YoY, beating consensus, and non-GAAP EPS of $2.56 topping estimates.

Expected impact

Likely modest support from the earnings beat, offset by concern over margin weakness and cash burn.

Evidence & confidence

The text provides both upside (revenue and EPS above consensus) and downside (gross margin miss, cash outflow $1.56B in Q3 and negative FCF margin), implying mixed near-term positioning.

Market effects

Signals ongoing pressure on margins and cash generation for agribusiness/consumer staples, even when top-line growth remains resilient.

Limited direct regional spillover; primarily affects US-listed staples/agri supply-chain sentiment.

Moderate read-through to global food, feed, and fuel demand expectations via Bunge’s diversified value chain.

Counterpoint

The revenue and EPS beat could be more durable than the cash-flow weakness suggests, especially if working-capital swings normalize next quarter.

Key entities

  • Bunge Global

    US-listed agribusiness company reporting Q3 2026 revenue and non-GAAP EPS versus consensus, alongside cash flow and margin commentary.

Related articles

$BGMed

What Bunge Global (BG) Said on Its Q3 Earnings Call

Bunge Global (BG) reported Q3 earnings with mixed results. Grain merchandising gains were offset by weaker ocean freight and milling results. CEO Greg Heckman highlighted integration progress with Viterra, expecting $200M in cost savings by 2026. The company anticipates $0.50 per share from synergies in 2027. Bunge generated $2B in adjusted funds from operations, with $1.6B in discretionary cash flow.

$BGHighAI 9/10

Bunge (BG) Q3 2026 Earnings Call Transcript

Bunge (BG) reported Q3 2026 EPS of $1.64, up from $0.86 in 2025. Adjusted EPS was $2.56, with adjusted EBIT at $997M. The company maintained its full-year adjusted EPS guidance of $9.25-$9.75. Bunge highlighted progress from its Viterra combination, including cost savings and new projects. It also announced the sale of non-core sugar mills in Brazil. The company's liquidity position remains strong, with $9.7B in credit facilities.

$BGMedAI 8/10

Bunge Global 3Q 2026: Revenue $23.8B, Net income $318M, EPS $1.64— 10-Q Summary

Bunge Global reported Q3 2026 revenue of $23.8B, net income of $318M, and EPS of $1.64, up from $22.16B, $166M, and $0.84 respectively in the prior-year quarter. Nine-month net sales rose 50% to $69.7B, driven by Viterra and higher commodity prices. Soybean and softseed segment EBIT increased significantly, while sugarcane mill sale charges and Ukraine-related inventory damage weighed on results.

$BGHighAI 8/10

Bunge Q3 2026 slides: earnings beat offset by rising costs

Bunge (BG) reported Q3 2026 adjusted EPS of $2.56, beating estimates but shares fell slightly due to higher costs. The company maintained full-year guidance and highlighted benefits from Viterra integration. Adjusted segment EBIT rose 7.9% YoY, with strong performance in soybean and softseed processing, but declines in tropical oils and grain merchandising.

$BGMedAI 8/10

Bunge Q3 2026: Net Income $318 Million, Adjusted EPS $2.56

Bunge reported Q3 2026 net income of $318M, up from $166M YoY. Adjusted EPS was $2.56, and revenue reached $23.8B. The company maintained its full-year adjusted EPS outlook of $9.25-$9.75. Soybean processing improved, while Tropical Oils faced geopolitical disruptions. Bunge also announced the sale of two Brazilian sugarcane mills and progress on Viterra synergies.